| Literature DB >> 31992633 |
Chenxia Cao1,2, Jicheng Wang1,2, Yangshuo Liu1,2, Lai-Yu Kwok1,2, Heping Zhang1,2, Wenyi Zhang3,2.
Abstract
The widespread use of antibiotics has caused great concern in the biosafety of probiotics. In this study, we conducted a 12-month adaptive laboratory evolution (ALE) experiment to select for antibiotics-adapted Lactobacillus plantarum P-8, a dairy-originated probiotic bacterium. During the ALE process, the ampicillin MIC for the parental L. plantarum P-8 strain increased gradually and reached the maximum level of bacterial fitness. To elucidate the molecular mechanisms underlying the ampicillin-resistant phenotype, we comparatively analyzed the genomes and proteomes of the parental strain (L. plantarum P-8) and two adapted lines (L. plantarum 400g and L. plantarum 1600g). The adapted lines showed alterations in their carbon, amino acid, and cell surface-associated metabolic pathways. Then, gene disruption mutants were created to determine the role of six highly expressed genes in contributing to the enhanced ampicillin resistance. Inactivation of an ATP-dependent Clp protease/the ATP-binding subunit ClpL, a small heat shock protein, or a hypothetical protein resulted in partial but significant phenotypic reversion, confirming their necessary roles in the bacterial adaptation to ampicillin. Genomic analysis confirmed that none of the ampicillin-specific differential expressed genes were flanked by any mobile genetic elements; thus, even though long-term exposure to ampicillin upregulated their expression, there is low risk of spread of these genes and adapted drug resistance to other bacteria via horizontal gene transfer. Our study has provided evidence of the biosafety of probiotics even when used in the presence of antibiotics.IMPORTANCE Antibiotic resistance acquired by adaptation to certain antibiotics has led to growing public concerns. Here, a long-term evolution experiment was used together with proteomic analysis to identify genes/proteins responsible for the adaptive phenotype. This work has provided novel insights into the biosafety of new probiotics with high tolerance to antibiotics.Entities:
Keywords: Lactobacillus; Lactobacillus plantarum P-8; adaptive laboratory evolution; ampicillin; antibiotics; parallel reaction monitoring; proteomics
Year: 2020 PMID: 31992633 PMCID: PMC6989132 DOI: 10.1128/mSystems.00853-19
Source DB: PubMed Journal: mSystems ISSN: 2379-5077 Impact factor: 6.496
FIG 1Changes in the drug MICs for L. plantarum P-8 during the 12-month adaptive laboratory evolution experiment. A-1 and C-1, A-2 and C-2, and A-3 and C-3 represent bacterial line 1, line 2, and line 3, respectively. The three cell lines were derived from three individual colonies as indicated. Each assay was repeated three times.
FIG 2Distribution of SNPs on the genomes of L. plantarum 400g and L. plantarum 1600g. The inner circle illustrates the nucleotide position of the genome. The violet and yellow circles represent the genomes of L. plantarum 400g and L. plantarum 1600g, respectively. Specific genes are denoted by gene locus tags. The mutation occurring at an intergenic region is indicated in red.
FIG 3Volcano plot of the proteomic data of L. plantarum 400g (a) and L. plantarum 1600g (b). The x axis indicates the differential levels of protein expression (fold ratio between the parental L. plantarum P-8 and the adapted strains, 400g and 1600g, in a log-2 scale). The y axis indicates the statistical significance for the differential expression levels (P value generated from t test in log10 scale).
FIG 4Hierarchical clustering of differentially expressed proteins of L. plantarum 400g relative to L. plantarum P-8. Each row represents a differentially expressed protein, while data of each of the three biological replicates are plotted in one column. The color scale represents the protein expression level, ranging from −1 (minimal expression) to 1 (maximal expression).
FIG 5Hierarchical clustering of differentially expressed proteins of L. plantarum 1600g relative to L. plantarum P-8. Each row represents a differentially expressed protein, while data of each of the three biological replicates are plotted in one column. The color scale represents the protein expression level, ranging from −1 (minimal expression) to 1 (maximal expression).
FIG 6Functional distribution of differentially expressed proteins of ampicillin-adapted strains. Data represent upregulated (a) and downregulated (b) proteins of L. plantarum 400g and L. plantarum 1600g. Enrichment analyses were performed based on the protein expression of each COG functional category of L. plantarum 400g and L. plantarum 1600g relative to L. plantarum parental strain P-8. Significant enhancement is indicated by single and double asterisks (* represents P values of <0.05; ** represents P values of <0.01; Fisher’s exact test). COG functional categories are indicated as follows: C, energy production and conversion; D, cell cycle control, cell division, chromosome partitioning; E, amino acid transport and metabolism; F, nucleotide transport and metabolism; G, carbohydrate transport and metabolism; H, coenzyme transport and metabolism; I, lipid transport and metabolism; J, translation, ribosomal structure, and biogenesis; K, transcription; L, replication, recombination, and repair; M, cell wall/membrane/envelope biogenesis; O, posttranslational modification, protein turnover, chaperones; P, inorganic ion transport and metabolism; Q, secondary metabolites biosynthesis, transport, and catabolism; R, general function prediction only; S, function unknown; T, signal transduction mechanisms; V, defense mechanisms.
FIG 7Correlation between expression patterns of 10 selected proteins detected by TMT and PRM analyses. (a) L. plantarum 400g. (b) L. plantarum 1600g. For both the TMT and PRM analyses, peptides from three biological replicates of the protein samples were analyzed. The strength and statistical significance of Pearson’s correlations between fold changes found by TMT and PRM analyses are represented by the R and P values, respectively. Confidence intervals are illustrated by the gray area. LBP_cg0397, l-serine dehydratase, beta subunit; LBP_cg0885, malate dehydrogenase; LBP_cg1290, enoyl-(acyl carrier protein) reductase; LBP_cg1294, acyl-CoA thioester hydrolase; LBP_cg1793, penicillin binding protein 2B; LBP_cg0109, sHSP; LBP_cg0720, hypothetical protein; LBP_cg0721, alkaline shock protein; LBP_cg0722, alkaline shock protein; LBP_cg2905, ClpL.
FIG 8Ampicillin MICs for L. plantarum 400g and L. plantarum 1600g and their mutants. Each assay was repeated three times, and identical results were obtained in all cases.
FIG 9Amoxicillin MICs for L. plantarum 400g and L. plantarum 1600g and their mutants. Each assay was repeated three times, and identical results were obtained in all cases.
Strains, plasmids, and primers used in this study
| Strain, plasmid, or primer | Description or primer sequence | Reference or source |
|---|---|---|
| Strains | ||
| | Cloning host | This study |
| | Isolated from traditional fermented cow milk in Inner Mongolia, China | |
| | This study | |
| | This study | |
| | Derivative of 400g containing a | This study |
| | Derivative of 400g-1294:: | This study |
| | Derivative of 1600g containing a | This study |
| | Derivative of 1600g-0109:: | This study |
| | Derivative of 1600g containing a | This study |
| | Derivative of 1600g-0720:: | This study |
| | Derivative of 1600g containing a | This study |
| | Derivative of 1600g-0721:: | This study |
| | Derivative of 1600g containing a | This study |
| | Derivative of 1600g-0722:: | This study |
| | Derivative of 1600g containing a | This study |
| | Derivative of 1600g-0722-0721:: | This study |
| | Derivative of 1600g containing a | This study |
| | Derivative of 1600g-2905:: | This study |
| Plasmids | ||
| pNZ5319 | Cmr Emr; containing | |
| pNZ5319-0109Up-Down | Cmr Emr; pNZ5319 derivative containing homologous regions up- and downstream of LBP_cg0109 | This study |
| pNZ5319-0720Up-Down | Cmr Emr; pNZ5319 derivative containing homologous regions up- and downstream of LBP_cg0720 | This study |
| pNZ5319-0721Up-Down | Cmr Emr; pNZ5319 derivative containing homologous regions up- and downstream of LBP_cg0721 | This study |
| pNZ5319-0722Up-Down | Cmr Emr; pNZ5319 derivative containing homologous regions up- and downstream of LBP_cg0722 | This study |
| pNZ5319-0722-0721Up-Down | Cmr Emr; pNZ5319 derivative containing homologous regions up- and downstream of LBP_cg0721 in the strain of 1600G-Δ0722 | This study |
| pNZ5319-1294Up-Down | Cmr Emr; pNZ5319 derivative containing homologous regions up- and downstream of LBP_cg1294 | This study |
| pNZ5319-2905Up-Down | Cmr Emr; pNZ5319 derivative containing homologous regions up- and downstream of LBP_cg2905 | This study |
| pMSPCre | Emr; expression of | |
| Primers | ||
| 0109upF | 5′-CCG | This study |
| 0109upR | 5′-AGCTTT | This study |
| 0109downF | 5′-TCCC | This study |
| 0109downR | 5′-GGGTTT | This study |
| 0720upF | 5′-CCG | This study |
| 0720upR | 5′-AGCTTT | This study |
| 0720downF | 5′-TCCC | This study |
| 0720downR | 5′-GGGTTT | This study |
| 0721upF | 5′-CCG | This study |
| 0721upR | 5′-AGCTTT | This study |
| 0721downF | 5′-TCCC | This study |
| 0721downR | 5′-GGGTTT | This study |
| 0722upF | 5′-CCG | This study |
| 0722upR | 5′-AGCTTT | This study |
| 0722downF | 5′-TCCC | This study |
| 0722downR | 5′-GGGTTT | This study |
| 0722-0721upF | 5′-AGGACCGATAACGCG | This study |
| 0722-0721upR | 5′-CGGTAGATTTAAATT | This study |
| 0722-0721downF | 5′-ATACGAACGGTACAG | This study |
| 0722-0721downR | 5′-TTCTCGTAGCGATCG | This study |
| 1294upF | 5′-AGGACCGATAACGCG | This study |
| 1294upR | 5′-CGGTAGATTTAAATT | This study |
| 1294downF | 5′-ATACGAACGGTACAG | This study |
| 1294downR | 5′-TTCTCGTAGCGATCG | This study |
| 2905upF | 5′-CCG | This study |
| 2905upR | 5′-CT | This study |
| 2905downF | 5′-TCCC | This study |
| 2905downR | 5′-GGGTTT | This study |
| 85 | 5′-GTTTTTTTCTAGTCCAAGCTCACA-3′ | |
| 87 | 5′-GCCGACTGTACTTTCGGATCCT-3′ | |
| CatF | 5′-TCAAATACAGCTTTTAGAACTGG-3′ | |
| CatR | 5′-ACCATCAAAAATTGTATAAAGTGGC-3′ | |
| EryintF | 5′-CGATACCGTTTACGAAATTGG-3′ | |
| EryintR | 5′-CTTGCTCATAAGTAACGGTAC-3′ | |
| CreF | 5′-CTAACTCGAGTGATCACCAATTC-3′ | |
| CreR | 5′-GGCTATCAATCAAAGCAACACG-3′ |
The restriction sites in the primer sequences are underlined. Cmr, chloramphenicol resistance; Emr, erythromycin resistance.